Inhibitors of dihydroorotate dehydrogenase
- 1 January 1999
- journal article
- Published by Taylor & Francis in Expert Opinion on Therapeutic Patents
- Vol. 9 (1) , 41-54
- https://doi.org/10.1517/13543776.9.1.41
Abstract
Dihydroorotate dehydrogenase (DHODase) is the rate-limiting step in de novo pyrimidine biosynthesis, required for the proliferation of many cell types and for the growth of microorganisms. Inhibitors of this enzyme have potential as immunosuppressive agents for the prevention of organ transplant rejection, and for the treatment of autoimmune diseases such as rheumatoid arthritis (RA). Other possible applications are as anti-infective agents such as antimalarials and antibacterials. Two major chemical classes of mammalian DHODase inhibitors have been described in the literature, based on the drugs brequinar (BQR) and leflunomide (LFM). A few inhibitors of microbial enzymes have also been disclosed. Since DHODase inhibition has not yet been reviewed, this paper covers the patents and associated publications which have appeared during the past 13 years.Keywords
This publication has 30 references indexed in Scilit:
- Side effects of brequinar and brequinar analogues, in combination with cyclosporine, in the ratToxicology, 1998
- Active Site of Dihydroorotate Dehydrogenase A from Lactococcus lactis Investigated by Chemical Modification and MutagenesisBiochemistry, 1997
- A New Rational Hypothesis for the Pharmacophore of the Active Metabolite of Leflunomide, a Potent Immunosuppressive DrugJournal of Medicinal Chemistry, 1997
- The crystal structure of the flavin containing enzyme dihydroorotate dehydrogenase A from Lactococcus lactisStructure, 1997
- Functional Expression of a Fragment of Human Dihydroorotate Dehydrogenase by Means of the Baculovirus Expression Vector System, and Kinetic Investigation of the Purified Recombinant EnzymeEuropean Journal of Biochemistry, 1996
- Identification of a Novel Inhibitor (NSC 665564) of Dihydroorotate Dehydrogenase with a Potency Equivalent to BrequinarBiochemical and Biophysical Research Communications, 1996
- The Immunosuppressive Metabolite of Leflunomide Is a Potent Inhibitor of Human Dihydroorotate DehydrogenaseBiochemistry, 1996
- Dihydroorotate Dehydrogenase Is a High Affinity Binding Protein for A77 1726 and Mediator of a Range of Biological Effects of the Immunomodulatory CompoundJournal of Biological Chemistry, 1995
- Immunosuppressive structure-activity relationships of Brequinar and related cinchoninic acid derivativesBioorganic & Medicinal Chemistry Letters, 1995
- Cyclosporin A: Review of results in organ and bone‐marrow transplantation in manMedicinal Research Reviews, 1984